RNXT
RenovoRx Inc
1.60$
+1.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -5,651.2% | -1,716.2% | -545.5% | -853.4% | -1,268.9% | -658.8% | -315.4% | -600.5% | |
| – | – | – | – | – | – | 0.5% | 0.2% | -0.4% | 0.4% | 0.2% | 0.6% | 0.3% | |
| – | – | – | – | – | 586.0% | 146.2% | 81.8% | 131.2% | 119.7% | 56.3% | 62.7% | 77.0% | |
| – | – | – | – | – | -330.2% | -349.2% | -29.1% | 167.7% | 49.6% | -111.2% | -32.2% | -18.0% | |
| – | – | – | – | – | 0.0% | 1.0% | 0.0% | 0.0% | 0.0% | 11.7% | 7.8% | 6.9% | |
| – | – | – | – | – | – | -1.0% | – | – | – | 11.7% | -7.8% | – | |
| – | – | – | – | – | 76.7% | 5,487.8% | 8.1% | 0.0% | 0.0% | 1,606.9% | 6.1% | 460.6% | |
| – | – | – | – | – | -5,602.3% | 3,770.6% | -537.4% | -853.4% | -1,268.9% | 948.1% | -317.2% | -143.5% | |
| – | – | – | – | – | -5,679.1% | -1,717.3% | -545.5% | -853.4% | -1,268.9% | -658.8% | -323.2% | -604.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.